Published in
Impact Journals, Oncotarget, 33(7), p. 53377-53391, 2016
DOI: 10.18632/oncotarget.10535
Links
Tools
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
Journal article published in 2016 by
Andrea Ghelli Luserna Di Rorà,
Di Rorà Ag,
Andrea Ghelli Luserna Di Rorà,
Andrea Ghelli Luserna Di Rorà,
Ilaria Iacobucci,
Enrica Imbrogno,
Cristina Papayannidis 
,
Enrico Derenzini,
Anna Ferrari ,
Viviana Guadagnuolo,
Valentina Robustelli,
Sarah Parisi,
Chiara Sartor,
Abbenante Mc,
Maria Chiara Abbenante
and other authors.
,
Enrico Derenzini,
Anna Ferrari ,
Viviana Guadagnuolo,
Valentina Robustelli,
Sarah Parisi,
Chiara Sartor,
Abbenante Mc,
Maria Chiara Abbenante
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 